Biomarker measurement
We provide a unique total solution using biomarkers throughout the entire value chain of drug development, from the early stages of development to application!
In recent years, the evaluation using biomarkers has been actively incorporated at various stages of drug discovery. We possess a diverse range of analytical instruments, including the "Orbitrap Q Exactive Plus," "Triple Quad 6500+," and "MESO SECTOR S 600." [Overview] ■ Early Development: Comprehensive evaluation of various markers as pharmacological indicators ■ Application Submission: If applicable to the primary evaluation criteria, implementation starts from obtaining measurement method validation *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Equipment Owned (Excerpt)】 ■Orbitrap Q Exactive Plus ■Triple Quad 6500+ ■MESO SECTOR S 600 ■Spectra Max M4 ■Tape Station ■Gyrolab ■Canto II ■Fortessa X-20 ■Quant Studio 5 ■NanoDrop ■Cell Culture Experimental Equipment ■BSL2 Facility *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
■ Biomarker Analysis From screening measurements in exploratory areas, validation tests, and the development of analytical methods tailored to specific objectives at each stage, to analytical method validation (Fit for Purpose), measurement of non-clinical and clinical samples, and sample banking, we support the entire value chain of drug development using these biomarkers, ensuring that your development compounds quickly progress through non-clinical and clinical phases and reach the market. *For more details, please refer to the PDF materials or feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
CMIC Pharma Science Co., Ltd. CMIC Bioreseach Center, Kobe Laboratory, Sapporo Laboratory
Our company, as a Non-Clinical CRO, provides solutions in the non-clinical field throughout the entire product lifecycle, from research and development stages to commercial stages, including preclinical research, bioanalysis, CMC quality analysis, analysis/measurement of biopharmaceuticals across these areas, consulting, medical writing, and more for pharmaceuticals and medical devices. In close collaboration with our group companies, we fully support our customers' value chain from product development to manufacturing, sales, and marketing across the US, Europe, and Asia. Please feel free to contact us if you have any inquiries.
![Dioxin Rapid Test Method (Bioassay Method) [*Technical materials available!]](https://image.mono.ipros.com/public/product/image/923/2000279310/IPROS409129405468944640.jpg?w=280&h=280)
